Previous 10 | Next 10 |
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Zafgen, Inc. (“Zafgen” or the “Company”) (NASDAQ: ZFGN ) investors concerning the Company and its officers’ possible violations of federal securities laws. ...
A few years ago on this blog, I wrote several times about a small company called Zafgen (ZFGN) and their unusual epoxide-based chemical matter (beloranib) that was in development for the rare Prader-Willi syndrome . That's a genetic disorder that includes, among many other problems, constan...
BOSTON, March 13, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients affected by a range of metabolic diseases, announced today that Jeffr...
The following slide deck was published by Zafgen, Inc. in conjunction with this Read more ...
Gainers: VivoPower International (NASDAQ: VVPR ) +52% . ENDRA Life Sciences (NASDAQ: NDRA ) +41% . Leap Therapeutics (NASDAQ: LPTX ) +31% . Stitch Fix (NASDAQ: SFIX ) +30% . Seelos Therapeutics (NASDAQ: SEEL ) +26% . Key Energy Services (NYSE: KEG ) +24% . Chaparral Energy (NYS...
Zafgen (NASDAQ: ZFGN ) -26% on suspension of IND for ZGN-1258. More news on: Zafgen, Inc., Pyxis Tankers Inc., ADT Inc., Stocks on the move, Read more ...
Zafgen, Inc. (ZFGN) Q4 2018 Earnings Conference Call March 11, 2019 16:30 ET Company Participants John Woolford - IR, Westwicke Partners Jeffrey Hatfield - CEO Patricia Allen - CFO Conference Call Participants Ted Tenthoff - Piper Jaffray Presentation Operator Goo...
Gainers: NM +22.9% . SFIX +19.1% . NOG +4.5% . OTCQB:HLIX +2.8% . TNXP +2.4% . More news on: Navios Maritime Holdings Inc., Stitch Fix, Inc., Northern Oil and Gas, Inc., Stocks on the move, Read more ...
Thinly traded micro cap Zafgen (NASDAQ: ZFGN ) slumps 27% after hours in apparent response to its disclosure that it has suspended plans to file an IND in the U.S. seeking signoff to start clinical development of ZGN-1258 for the trial of metabolic disorder called Prader-Willi ...
Zafgen (NASDAQ: ZFGN ): Q4 GAAP EPS of -$0.39 beats by $0.05. More news on: Zafgen, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Zafgen Company Name:
ZFGN Stock Symbol:
NASDAQ Market:
- Shares of combined company to commence trading on Nasdaq Global Market under the symbol “LRMR” on May 29, 2020 - Company signed $80 million in private placement financing with biotechnology focused institutional investors - New Board Chair, Chief Medical Officer and Chi...
These Penny Stocks Moved Big But Can They Continue Higher Before Next Year? Over the course of the year, plenty of penny stocks have generated significant gains for investors. Even as the year comes to a close, there are some penny stocks that are gaining momentum. It is often said that inve...
Creates clinical-stage company focused on the development of novel protein replacement therapies for rare diseases Chondrial Therapeutics’ lead asset, CTI-1601, currently being evaluated in Phase 1 clinical trial for Friedreich’s ataxia Companies to host confere...